Companies / BDX vs BSX
BDX vs BSX: Becton Dickinson and Boston Scientific
Becton Dickinson (BDX) reported $21.8B in revenue against a 7.7% net margin, while Boston Scientific (BSX) reported $20.1B at a 14.4% net margin, most recently.
| Metric | BDX | BSX |
|---|---|---|
| Revenue | $21.8B | $20.1B |
| Net Income | $1.7B | $2.9B |
| Gross Margin | 45.4% | 69.0% |
| Operating Margin | 11.8% | 18.0% |
| EPS (Diluted) | $5.82 | $1.94 |
| Free Cash Flow | $2.7B | $3.7B |
| Total Debt | $19.2B | $11.4B |
| P/E Ratio | 32.2× | 49.2× |
| P/B Ratio | n/m | n/m |
| Stock Price | $211.95 | $44.62 |
Free: last 5 years
| Fiscal year | FY2007 🔒 | FY2008 🔒 | FY2009 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BDX Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $19.1B | $18.9B | $19.4B | $20.2B | $21.8B |
| BSX Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $11.9B | $12.7B | $14.2B | $16.7B | $20.1B |